aha shape symposium 2017 dr. naghavi presentation
TRANSCRIPT
![Page 1: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/1.jpg)
Morteza Naghavi, M.D. Founder and Executive Chairman of SHAPE
The 2nd Machine Learning
Vulnerable Patient Symposium
Towards Developing an Artificial Intelligence-Based Forecast System
for
Predicting Short-Term CVD Events
A Satellite Event in Conjunction with 2017 Annual Scientific Sessions of American Heart Association
![Page 2: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/2.jpg)
Let’s Begin with
the End
![Page 3: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/3.jpg)
Goal:
Eradicate Heart
Attacks(Unpredicted CVD Events)
![Page 4: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/4.jpg)
Now Let’s See
Where We Are
![Page 5: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/5.jpg)
Last year2,626,418 people died
in the US
614,348 (23.4%) of them
died due to heart disease and
133,033 (5.1%) due to stroke
Total 747,381 (28.5%)
![Page 6: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/6.jpg)
Unlike Cancer
• Unlike in cancer where oncologists deal
with hundreds of different pathologies and
specific therapeutic strategies, in CVD over
50% of cases we deal with one pathology:
Atherosclerosis(The number 1 killer of mankind)
![Page 7: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/7.jpg)
Unpredicted
![Page 8: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/8.jpg)
In >50% of victims,
the first symptom of
asymptomatic
atherosclerosis is a
sudden cardiac
death or acute MI.
![Page 9: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/9.jpg)
Men
Women
0 10 20 30 40 50 60 70
Patients Diagnosed with CHD (%)Murabito et al Circulation 1993
Sudden Cardiac Death or Acute MI
as Initial Presentation of CHD
62%
42%
![Page 10: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/10.jpg)
Add 10yrs to Life Expectancy of
Mankind
Early detection and treatment of
atherosclerosis to prevent acute CVD
events is likely to increase life
expectancy in excess of 10 years.
That’s HUGE!!!A Vaccination Type Impact on Public Health
![Page 11: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/11.jpg)
How Do We Get There?
A heart-attack free
future
![Page 12: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/12.jpg)
Let’s Draw an Analogy
Heart Attack
vs. Hurricane
![Page 13: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/13.jpg)
Imagine if the weatherman says there
is a 7.5% chance of a category 5 hurricane in
the next 10 years. Do you think people would
take immediate preventive actions like boarding
up their windows, buying hurricane supplies, or
even changing their daily routines?
![Page 14: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/14.jpg)
Imagine if heart attack and stroke were
predicted similar to hurricanes Harvey and Irma
with sufficient short-term alerts to at-risk people
to take preventive actions.
![Page 15: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/15.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 16: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/16.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 17: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/17.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 18: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/18.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 19: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/19.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 20: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/20.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 21: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/21.jpg)
Heart Attack vs. HurricaneTHE GALVESTON HORROR
![Page 22: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/22.jpg)
Heart Attack vs. Hurricane10-year Risk Prediction vs. 10-day Risk Prediction
![Page 23: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/23.jpg)
![Page 24: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/24.jpg)
![Page 25: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/25.jpg)
What has SHAPE done?
![Page 26: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/26.jpg)
Naghavi et. al. Circulation Journal
The Vulnerable Patient Consensus Statement
![Page 27: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/27.jpg)
Naghavi et. al. Circulation Journal
The Vulnerable Patient Consensus Statement
![Page 28: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/28.jpg)
SHAPE Task Force Meeting
![Page 29: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/29.jpg)
![Page 30: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/30.jpg)
SHAPE Guidelines Published
![Page 31: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/31.jpg)
![Page 32: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/32.jpg)
Coronary Artery Calcium Score
32
![Page 33: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/33.jpg)
The Writing Sub-Committee of the SHAPE Task Force (left to right): Drs Budoff, Falk, Rumberger, Naghavi,
Fayad, Hecht, and Berman
![Page 34: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/34.jpg)
Atherosclerosis Test
Very Low Risk3
Negative Test• CACS =0
• CIMT <50th percentile
LowerRisk
ModerateRisk
Positive Test• CACS ≥1
• CIMT 50th percentile or Carotid Plaque
ModeratelyHigh Risk
HighRisk
VeryHigh Risk
No Risk Factors5 + Risk Factors • CACS <100 & <75th%
• CIMT <1mm & <75th%
& no Carotid Plaque
• Coronary Artery Calcium Score (CACS)
or
• Carotid IMT (CIMT) & Carotid Plaque4
• CACS 100-399 or >75th%
• CIMT 1mm or >75th%
or <50% Stenotic Plaque
• CACS >100 & >90th%
or CACS 400
• 50% Stenotic Plaque6
LDL
Target
<160 mg/dl <130 mg/dl <130 mg/dl
<100 Optional
<100 mg/dl
<70 Optional
<70 mg/dl
Re-test Interval 5-10 years 5-10 years Individualized Individualized Individualized
All >75y receive unconditional treatment2
Apparently Healthy Population Men>45y Women>55y1
ExitExit
Myocardial
IschemiaTest
NoAngiography
Follow Existing
Guidelines
Yes
The 1st
SHAPE Guidelines
Step 1
Step 2
Step 3Optional
CRP>4mg
ABI<0.9
1: No history of angina, heart attack, stroke, or peripheral arterial disease.
2: Population over age 75y is considered high risk and must receive therapy without testing for
atherosclerosis.
3: Must not have any of the following: Chol>200 mg/dl, blood pressure >120/80 mmHg, diabetes,
smoking, family history, metabolic syndrome.
4: Pending the development of standard practice guidelines.
5: High cholesterol, high blood pressure, diabetes, smoking, family history, metabolic syndrome.
6: For stroke prevention, follow existing guidelines.
![Page 35: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/35.jpg)
Existing Guidelines (Status Quo):
• Screen for Risk Factors of Atherosclerosis
• Treat Risk Factors of Atherosclerosis
The SHAPE Guidelines:
• Screen for Atherosclerosis (the Disease) Regardless of Risk Factors
• Treat based on the Severity of the Disease and its Risk Factors
SHAPE v.s. Status Quo
![Page 36: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/36.jpg)
Number
(per year)
Estimated Impact
of SHAPE
(Sensitivity
Analysis Range)
Estimated
Change in
Cost
CVD Deaths 910,600 ↓10%
(5%-25%)
($1.2 b)
MI (prevalence) 7,200,000 ↓ 25%
(5%-35%)
($18.0 b)
Chest Pain Symptoms (ER visits) 6,500,000 ↓ 5%
(2.5%-25%)
($4.1 b)
Hospital Discharge for Primary Diagnosis of CVD 6,373,000 ↑ 10%
(5%-25%)
$3.8 b
Hospital Discharge for Primary Diagnosis of CHD 970,000 ↓ 10%
(5%-25%)
($9.9 b)
Cholesterol Lowering Therapy ↑ 50 %
(50%-65%)
8.00 b
CV Imaging 8,700,000 ↑ 10%
(5%-25%)
$358 m
Angiography 6,800,000 ↑ 15% - CTA
(2.5%-25%)
$600 m
PCI (percutaneous coronary interventions per year) 657,000 ↓ 10%
(5%-50%)
($580 m)
CABS (coronary artery bypass surgeries per year) 515,000 ↓ 5%
(2.5%-50%)
($672 m)
Total Δ in Cost ($21.5 b)
Cost Effectiveness of the SHAPE Guidelines
![Page 37: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/37.jpg)
Heart Attack vs. Hurricane10-year Risk Prediction vs. 10-day Risk Prediction
![Page 38: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/38.jpg)
Long term predictions do not
trigger immediate preventive
actions.
Preventive cardiology needs a
short-term predictor.
![Page 39: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/39.jpg)
Heart Attack vs. Hurricane
![Page 40: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/40.jpg)
Machine Learning Vulnerable
Patient Project.
![Page 41: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/41.jpg)
http://shapesociety.org/videos-2/
![Page 42: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/42.jpg)
http://shapesociety.org/videos/
![Page 43: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/43.jpg)
The Big Idea:Developing an Artificial Intelligence-based Forecast System for
Prediction of Heart Attacks within 12 Months
Use machine learning to create new algorithms to detect who will experience
a CHD event within a year (The Vulnerable Patient). Algorithms will be
based on banked biospecimen and information collected days up to 12
months prior to the event. We will utilize existing cohorts such as MESA,
Heinz Nixdorf Recall Study, Framingham Heart Study, BioImage Study and
the Dallas Heart Study. External validation to test for discrimination and
calibration will be conducted using other longitudinal observational studies
that provide adjudicated cardiovascular event information such as the
MiHeart, JHS, DANRISK and ROBINSCA. Additionally, we will use machine
learning to characterize individuals who, despite high conventional risk, have
lived over 80 years with no CHD events (The Invulnerable). We expect to
discover new targets for drug and possibly vaccine development. We will
make the algorithms available as an open source tool to collect additional data
over time and increase its predictive value.
![Page 44: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/44.jpg)
What a great idea, what are you
waiting for?
Funding!
![Page 45: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/45.jpg)
Will Super Intelligent Computers Replace
Physicians?
![Page 46: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/46.jpg)
![Page 47: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/47.jpg)
Will Super Intelligent Computers
Replace Physicians?
Absolutely Yes
When and in What Areas?
Umm let’s discuss
![Page 48: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/48.jpg)
Inspired by IBM Watson
![Page 49: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/49.jpg)
Google DeepMind
49
![Page 50: AHA SHAPE Symposium 2017 Dr. Naghavi Presentation](https://reader031.vdocuments.mx/reader031/viewer/2022030318/5a64947b7f8b9a63568b4be5/html5/thumbnails/50.jpg)
Machine vs. Cardiologist